Skip to main content

PsA/SpA

Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Domain Strategy and Treatment in Psoriatic Arthritis: Dr. Elaine Husni Dr. Elaine Husni reviews her talk on domain strategies in PsA at the 2019 ACR/ARP annual meeting in Atlanta.
Depression in Psoriatic Arthritis: Dr. Olga Petryna Dr. Petryna discusses the association between depression and rheumatologic conditions, including psoriatic arthritis, highlighting abstracts #178, #580, #1490 and more.
Gender Differences in Ankylosing Spondylitis: Dr. Torkell Juulsgaard Dr. Juulsgaard discusses abstract #563 presented at the 2019 ACR/ARP annual meeting in Atlanta.
What's Happening at ACR 2019: Dr. Arthur Kavanaugh Dr. Arthur Kavanaugh previews what he's looking forward to at the 2019 ACR/ARP Annual Meeting in Atlanta.
Welcome to ACR 2019: Dr. Jack Cush Dr. Jack Cush gives an overview of RheumNow's 2019 ACR/ARP annual meeting coverage in Atlanta.
RN.podcast.resized_33.jpg
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.Study of ANA+ people without lupus or CTD shows that fatigue does not increase odds of having lupus or CTD. 1/3…
PSA2L_4.jpg
A cohort study of 97 patients with psoriatic arthritis (PsA) examined the prescribing practices in PsA, and found biologics are commonly initiated as the primary mode of therapy in outpatients with…
×